MedTrace Logo

Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers

NCT05428748 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-07-29

No results posted yet for this study

Summary

This clinical trial design aims to evaluate the safety and tolerability of a novel hydration drink in health volunteers.

Conditions

  • Tolerance

Interventions

OTHER

1 serving of test product

Participants will consume 1 serving/day of the test product for 28 days

OTHER

2 servings of test product

Participants will consume 2 servings/day of the test product for 28 days

OTHER

3 servings of test product

Participants will consume 3 servings/day of the test product for 28 days

OTHER

Placebo

Participants will consume 1 serving/day of the placebo for 28 days

Sponsors & Collaborators

  • University of Memphis

    collaborator OTHER

  • Liquid I.V.

    lead OTHER

Principal Investigators

  • Richard Bloomer, PhD · University of Memphis

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-02-01
Completion
2023-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05428748 on ClinicalTrials.gov